Therapeutic Group: Cardiovascular Presentation Feelnor 35 MR tablet: Each modified release tablet contains Trimetazidine Dihydrochloride BP 35 mg. Description Feelnor (Trimetazidine) is a unique antianginal and anti-ischaemic agent that display anti-ischaemic effects without inducing haemodynamic changes and improves the status of the ischaemic myocardium.The drug exerts its antianginal effects through a direct cytoprotective action on […]